Otida

High-Level Overview

Otida is an Egypt-based HealthTech company providing AI-powered SaaS solutions for chronic disease management, primarily targeting diabetes in hospitals and clinics.[1][2][6] It offers a comprehensive digital platform combining personalized nutrition plans, continuous remote monitoring via wearables, a patient mobile app, AI-driven analytics, and telehealth to reverse Type 2 diabetes and manage Type 1, while expanding to hypertension, obesity, and chronic kidney disease.[1][2][3][6] Serving patients, healthcare providers, and institutions in the Middle East, Otida solves fragmented chronic care by enabling real-time data insights, EHR integration, and multidisciplinary team collaboration, with early funding of $340,000 signaling growth momentum from investors like Flat6Labs and Afropreneurs.[1][5]

Origin Story

Otida was co-founded in Cairo, Egypt, by Ahmed Tawfic Saleh (CEO, CS from AUC, MBA from University of Chicago Booth, prior experience in consulting, business development, tech, and product at instadiet.me) and Ayman Mostafa (COO, BBus from AlexU, background in software development, digital marketing, and startups at egr2atk).[1][2] The idea emerged from addressing diabetes management gaps, building on Saleh's earlier nutrition app instadiet.me, evolving into a full chronic care platform with AI and telemonitoring.[1][5] Early traction included raising $340,000 in 2022 from Afropreneurs, Flat6Labs, LoftyInc, UI Investments, and Jedar Capital, plus operational scaling with Inas Abdelwahed as Head of Medical Operations.[1][2][5]

Core Differentiators

• AI-Driven Personalization: Uses artificial intelligence for real-time patient data analysis, decision support, personalized coaching in nutrition/fitness, and predictive health insights via wearables and mobile app.[1][2][3][4]
• Integrated Care Model: Combines digital therapeutics, Arabic telehealth, EHR/API integration, and remote monitoring with a multidisciplinary team for seamless hospital-clinic workflows and patient empowerment.[1][2][6]
• Comprehensive Chronic Focus: Beyond diabetes (Type 1/2 reversal/management), covers hypertension, obesity, CKD; acts as virtual nutritionist, coach, and physician to reduce reliance on in-person visits.[3][5][6]
• Developer and Ecosystem Tools: Offers Healthcare API integration, AI patient engagement, and analytics for providers, fostering scalable adoption in underserved regions like Egypt.[1][2]

Role in the Broader Tech Landscape

Otida rides the digital health boom in emerging markets, where diabetes prevalence is surging (e.g., Middle East/North Africa) amid rising smartphone penetration and post-pandemic telehealth demand.[1][2][5] Timing aligns with AI advancements enabling predictive chronic care, countering market forces like healthcare worker shortages and high chronic disease costs through scalable SaaS.[3][6] It influences the ecosystem by pioneering Arabic-localized HealthTech, integrating with local EHRs, and attracting regional VC, potentially accelerating AI adoption in African/Arab startups for preventive care.[1][5]

Quick Take & Future Outlook

Otida is positioned for expansion into more chronic conditions and pan-African/MENA markets, leveraging AI enhancements and partnerships with hospitals for subscription revenue growth.[6] Trends like wearable proliferation, regulatory support for digital therapeutics, and VC influx into HealthTech will propel it, evolving from diabetes specialist to full chronic care leader—potentially mirroring global players like Livongo while dominating local gaps.[2][3] Watch for Series A funding and outcome data proving reversal rates to cement its transformative edge in accessible care.